Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Worsley Investors director makes share purchase

(Sharecast News) - Worsley Investors revealed on Thursday that non-executive director William Scott had acquired 35,000 ordinary shares in the London-listed closed-end investment company. Scott, who joined the company as an independent director in March 2019, purchased the shares on Tuesday at an average price of 28.0p each, for a total value of £9,800.

As of 1620 GMT, Worsley shares were up 1.78% at 28.60p.

Reporting by Iain Gilbert at

Top Director Buys

Oryx International Growth Fund Ltd. (OIG) Director name: Mills,Christopher Amount purchased: 2,500 @ 1,232.00p Value: £30,800.00

Worsley Investors Limited Npv (WINV) Director name: Scott,William Amount purchased: 35,000 @ 28.00p Value: £9,800.00

Personal Assets Trust (PNL) Director name: Clements,Mandy Amount purchased: 207 @ 479.37p Value: £992.30

Britvic (BVIC) Director name: Litherland,Simon Amount purchased: 19 @ 784.64p Value: £149.08

Britvic (BVIC) Director name: Wilson,Joanne Amount purchased: 19 @ 784.64p Value: £149.08

Top Director Sells

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.